Clearmind Medicine, CMND, FDA, Psychedelic Therapies, Neuroplastogens, Non-Hallucinogenic Neuroplastogens, Alcohol Use Disorder, AUD, Addiction, Neuropsychiatric Disorders

VANCOUVER, Canada — October 7, 2026 Clearmind Medicine announced that it has submitted recommendations to the U.S. Food and...